Learn More
Medchemexpress LLC Monomethyl auristatin E | 474645-27-7 | MFCD09935109 | C68H105N9O15 | 100 MG

Supplier: Medchemexpress LLC HY15162G100MG
Monomethyl auristatin E (MMAE) (GMP) is a tubulin polymerization inhibitor produced using GMP guidelines.
- Produced using GMP guidelines
- Tubulin polymerization inhibitor
- Efficiently released from SGN-35 within CD30+ cancer cells
- Able to exert cytotoxic activity on bystander cells due to membrane permeability
- Sensitizes colorectal and pancreatic cancer cells to IR in a schedule and dose-dependent manner correlating with mitotic arrest
- Radiosensitization evidenced by decreased clonogenic survival and increased DNA double-strand breaks in irradiated cells
- In combination with IR, results in tumor growth delay
- Tumor-targeted ACPP-cRGD-MMAE with IR produces a more robust and significantly prolongs tumor regression in xenograft models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.